Cerevka v. Commissioner of the Social Security Administration

CourtDistrict Court, S.D. New York
DecidedJanuary 28, 2025
Docket1:23-cv-11261
StatusUnknown

This text of Cerevka v. Commissioner of the Social Security Administration (Cerevka v. Commissioner of the Social Security Administration) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cerevka v. Commissioner of the Social Security Administration, (S.D.N.Y. 2025).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK

SUSANNE INGRID C.,

Plaintiff,

CIVIL ACTION NO. 23 Civ. 11261 (LJL) (RFT) -v-

REPORT AND RECOMMENDATION

MICHELLE KING, ACTING COMMISSIONER OF SOCIAL SECURITY,1

Defendant.

TO THE HONORABLE LEWIS J. LIMAN, UNITED STATES DISTRICT JUDGE: Plaintiff Susanne Ingrid C. seeks judicial review of a final determination by Defendant Michelle King, Acting Commissioner (the “Commissioner”) of the Social Security Administration (the “SSA”), denying her application for benefits under the Social Security Act (the “Act”). (See ECF 9, Pl.’s Br. at 2.)2 Plaintiff seeks to vacate the Commissioner’s decision and remand for further administrative proceedings. (See id.) Having carefully reviewed the administrative record (the “Record”) and the submissions of the parties, and for the reasons set forth below, I respectfully recommend that Plaintiff’s motion should be GRANTED and that this matter should be remanded for further proceedings.

1 Michelle King is the Acting Commissioner of the Social Security Administration. Pursuant to Rule 25(d) of the Federal Rules of Civil Procedure, she is substituted as the defendant in this action. 2 To protect Plaintiff’s privacy, she is identified by her first and middle names and last initial. BACKGROUND I. Procedural History

Plaintiff filed a claim for Supplemental Security Income (“SSI”) on August 12, 2021. (See R. at 10, 117-19.)3 She alleged disability beginning on December 2, 2018. (See id. at 10, 117.) Her claims were denied first on December 9, 2021, and then on reconsideration on March 16, 2022. (See id. at 126, 135.) Plaintiff requested a hearing before an Administrative Law Judge (“ALJ”), which was held

on September 9, 2022, by ALJ Ifeoma N. Iwuamadi via telephone due to the pandemic. (See id. at 171-76, 223-24.) The ALJ issued a decision dated December 22, 2022, finding that Plaintiff was not disabled and denying her SSI application. (See id. at 7-9.) Plaintiff asked for review of the ALJ’s decision on January 6, 2023, and the Appeals Council denied the request on November 6, 2023. (See id. at 1-3, 238-40.) She now appeals the agency’s final decision. II. Administrative Record

A. Plaintiff’s Background and Symptoms Plaintiff was born in 1972 and was 46 years old at the time she allegedly became disabled. (See id. at 24, 59, 117.) She has a degree in psychology from Boston University. (See id. at 59.) At the time of her hearing, Plaintiff had not worked since August 12, 2021. (See id. at 12.)

Plaintiff had previously worked as a consultant in marketing, promotions, and public relations. (See id. at 16.) In the disability report completed with her SSI application, she alleged disability

3 Citations to “R.” are to the administrative record, and the page citations are to the numbers in the lower right corner of each page and not to the numbers at the top of the page that are part of the ECF numbering system. beginning on December 2, 2018, due to anxiety disorder, depression, bipolar disorder, back problems, and headaches. (See id. at 98.) B. Medical Evidence

Plaintiff’s alleged onset date is December 2, 2018. (See id. at 82.) The earliest medical records in the Record date from 2020. Beginning in 2020, Plaintiff saw at least nine different doctors, including treating physicians, a consultative examiner, a psychological consultant, a medical consultant, psychotherapists, and a psychiatrist. (See id. at 323-24, 332, 343, 347, 353- 54, 362, 370, 372, 429, 466-68.) She received therapy and psychotherapy weekly for approximately five months between August 30, 2021 and January 2022. (See id. at 353, 380,

418-19.) Plaintiff was treated with various prescription medications, including: Abilify for mood stabilization, Vistaril for anxiety, Prilosec for gastroesophageal reflux disease, and Imitrex for headaches. (See id. at 353.)4

4 Abilify is a brand-name formulation of aripiprazole, a drug that is prescribed for, among other conditions, “episodes of mania or mixed episodes (symptoms of mania and depression that happen together) in adults, teenagers, and [some] children . . . with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods).” See Aripiprazole, U.S. NATIONAL LIBRARY OF MEDICINE: MEDLINE PLUS, https://medlineplus.gov/druginfo/meds/a603012.html (last visited Jan. 21, 2025). Prilosec, a brand-name formulation of omeprazole, is used alone or with other medications to treat the symptoms of gastroesophageal reflux disease (“GERD”) and certain ulcers. See Omeprazole, https://medlineplus.gov/druginfo/meds/a693050.html U.S. NATIONAL LIBRARY OF MEDICINE: MEDLINE PLUS (last visited Jan. 21, 2025). Imitrex is a brand-name formulation of sumatriptan, which is used to treat the symptoms of migraine headaches. See Sumatripan, U.S. NATIONAL LIBRARY OF MEDICINE: MEDLINE PLUS, https://medlineplus.gov/druginfo/meds/a601116.html (last visited Jan. 21, 2025). Vistaril is also known as Hydroxyzine, which is indicated to help control anxiety and tension caused by nervous emotional conditions. See Hydroxyzine (oral route), MAYO CLINIC, https://www.mayoclinic.org/drugs-supplements/hydroxyzine-oral- route/description/drg-20311434 (last visited Jan. 15, 2025). 1. Treatment History a. S&G Family Medical Office/Dr. Michael Guo, M.D.

On September 22, 2020, Dr. Michael Guo, one of Plaintiff’s treating physicians, evaluated Plaintiff for anxiety. On examination, Dr. Guo noted that Plaintiff presented without mood swings or memory loss. (See id. at 323, 428-29.) Dr. Guo diagnosed Plaintiff with generalized anxiety disorder, abnormal weight gain, and obesity. (See id. at 428-29.) b. Gouverneur Primary Care/Dr. Angelina M. Gomes, M.D.

Plaintiff received treatment at Gouverneur Primary Care, primarily from Dr. Angelina Gomes, her treating physician, from February 1, 2021 through August 15, 2022. (See id. at 331- 339, 379-87, 474-89, 469-471.) In the visit record from March 10, 2021, Dr. Gomes indicated that Plaintiff’s reason for her initial appointment was abdominal pain. (See id. at 332.) Dr. Gomes noted that it was

difficult to elicit Plaintiff’s specific symptoms due to pressured speech and tangential responses. (See id.) Dr. Gomes’s impression was that the abdominal symptoms related to Plaintiff’s stress levels. (See id. at 334.) In the visit record from January 26, 2022, Dr. Gomes evaluated Plaintiff for anxiety, noting that Plaintiff was a “bit more tangential and circumferential today than at prior visit.” (Id. at 379.) On August 15, 2022, Dr. Gomes completed a physical residual functional capacity

assessment, noting a diagnosis of anxiety and chronic low back pain. (Id. at 470.) Dr. Gomes concluded that Plaintiff’s mental health condition significantly limited her functional capacity and that Plaintiff had trouble with organization and concentration. (See id. at 471.) Dr. Gomes prescribed Plaintiff with Abilify for mood stabilization, Vistaril to decrease anxiety, Prilosec for GERD, and Imitrex for headaches. (See id.at 359.) c. Gouverneur Healthcare Services/Xinyi Wang, MSW, Ph.D Candidate.

Xinyi Wang saw Plaintiff for weekly individual therapy sessions starting in August 2021 to address anxiety and depression. (See id. at 353-54.) Progress notes taken by Therapist Wang between November 23, 2021 and January 25, 2022 stated that Plaintiff was living with a great amount of financial stress and experiencing physical health-related issues. (See id. at 380-94.) Therapist Wang stated that Plaintiff presented with a great amount of anxiety, exhibiting

tangential speech. (See id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Burgess v. Astrue
537 F.3d 117 (Second Circuit, 2008)
Thomas v. Arn
474 U.S. 140 (Supreme Court, 1986)
Genier v. Astrue
606 F.3d 46 (Second Circuit, 2010)
Townley v. Heckler
748 F.2d 109 (Second Circuit, 1984)
Williams v. Bowen
859 F.2d 255 (Second Circuit, 1988)
Whipple v. Astrue
479 F. App'x 367 (Second Circuit, 2012)
Brault v. Social Security Administration
683 F.3d 443 (Second Circuit, 2012)
Douglass v. Astrue
496 F. App'x 154 (Second Circuit, 2012)
Selian v. Astrue
708 F.3d 409 (Second Circuit, 2013)
Lamay v. Commissioner of Social SEC.
562 F.3d 503 (Second Circuit, 2009)
Zabala v. Astrue
595 F.3d 402 (Second Circuit, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
Cerevka v. Commissioner of the Social Security Administration, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cerevka-v-commissioner-of-the-social-security-administration-nysd-2025.